Abiopharma

AEON Biopharma Reports Third Quarter 2025 Results, Including Positive ABP-450 Biosimilarity Data and Strategic Positioning for Continued Growth

Zynex Announces Strategic Initiatives: Engagement of Province, Appointment of Paul Aronzon to Board of Directors, and Formation of Special Committee

Tenon Medical Announces Closing of $2.85 Million At-The-Market PIPE Financing

CDTX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Cidara Therapeutics, Inc. is Fair to Shareholders

IO Biotech, Inc. - IO Biotech Reports Third Quarter 2025 Financial Results and Provides Business Highlights

IO Biotech Reports Third Quarter 2025 Financial Results and Provides Business Highlights

Zynex Sets Third Quarter 2025 Earnings Call

Cocrystal Pharma Reports Third Quarter 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

bioAffinity Technologies Reports Third Quarter 2025 Financial Results